Analyst Upgrades and Downgrades For the Week of September 16th

September 20th:

Upgrades

• AGNC Investment (AGNC): Wells Fargo upgraded from Equal Weight to Overweight, price target increased from $10 to $12.
• Aptiv (APTV): Wells Fargo upgraded from Equal Weight to Overweight, price target raised from $78 to $87.
• Assembly Biosciences (ASMB): Jefferies upgraded from Hold to Buy, price target increased from $2 to $35.
• BOK Financial (BOKF): Truist upgraded from Hold to Buy, price target raised from $112 to $123.
• Centessa Pharmaceuticals (CNTA): Morgan Stanley upgraded from Equal-Weight to Overweight, price target increased from $11 to $26.
• Darden Restaurants (DRI): Evercore ISI upgraded from In-line to Outperform, price target raised from $165 to $205.
• Annaly Capital Mgmt (NLY): Wells Fargo upgraded from Equal Weight to Overweight, price target increased from $19 to $23.
• Visteon (VC): Wells Fargo upgraded from Equal Weight to Overweight, price target raised from $115 to $122.
• Campbell Soup (CPB): Argus upgraded from Hold to Buy.
• FirstEnergy (FE): Argus upgraded from Hold to Buy.
• Millicom International Cellular (TIGO): Scotiabank upgraded from Sector Perform to Sector Outperform.
• TIM S.A. (TIMB): Scotiabank upgraded from Sector Perform to Sector Outperform.

Downgrades

• Ares Commercial Real Estate (ACRE): Wells Fargo downgraded from Equal Weight to Underweight, price target decreased from $7.5 to $7.
• ASML (ASML): Morgan Stanley downgraded from Overweight to Equal-Weight.
• Burberry plc (BURBY): Jefferies downgraded from Hold to Underperform.
• Claros Mortgage Trust (CMTG): Wells Fargo downgraded from Equal Weight to Underweight, price target lowered to $8.
• Dana Inc (DAN): Wells Fargo downgraded from Equal Weight to Underweight, price target cut from $13 to $9.
• Darden Restaurants (DRI): Bernstein downgraded from Outperform to Market Perform, price target decreased from $190 to $180.
• FedEx (FDX): Morgan Stanley downgraded from Equal-Weight to Underweight, price target lowered from $215 to $200; also downgraded from Buy to Hold by HSBC Securities, price target decreased to $300.
• Notable Labs (NTBL): JMP Securities downgraded from Market Outperform to Market Perform.
• Par Pacific (PARR): Piper Sandler downgraded from Overweight to Neutral, price target lowered from $37 to $23.
• Prosperity Bancshares (PB): Truist downgraded from Buy to Hold, price target decreased from $81 to $79.
• PBF Energy (PBF): Piper Sandler downgraded from Neutral to Underweight, price target cut from $47 to $25.
• PepsiCo (PEP): Morgan Stanley downgraded from Overweight to Equal-Weight.
• Rapid7 (RPD): RBC Capital Markets downgraded from Outperform to Sector Perform.
• Swatch (SWGAY): Jefferies downgraded from Hold to Underperform.
• Velocity Financial (VEL): Wells Fargo downgraded from Overweight to Underweight, price target reduced to $20.
• Valero Energy (VLO): Piper Sandler downgraded from Overweight to Neutral, price target decreased from $169 to $123.
• Telecom Argentina (TEO): Scotiabank downgraded from Sector Perform to Sector Underperform.

Coverage Initiated

• Ameren (AEE): Jefferies rated Buy with a price target of $97.
• Advanced Energy (AEIS): Robert W. Baird rated Outperform with a price target of $128.
• American Electric (AEP): Jefferies rated Hold with a price target of $107.
• Affirm (AFRM): Susquehanna rated Positive with a price target of $52.
• Amkor (AMKR): KeyBanc Capital Markets rated Overweight with a price target of $38.
• Clearway Energy (CWEN): Jefferies rated Buy with a price target of $35.
• CyberArk (CYBR): RBC Capital Markets rated Outperform with a price target of $328.
• Dominion Energy (D): Jefferies rated Hold with a price target of $58.
• Duke Energy (DUK): Jefferies rated Buy with a price target of $138.
• Evergy (EVRG): Jefferies rated Buy with a price target of $70.
• Exelon (EXC): Jefferies rated Buy with a price target of $46.
• IdaCorp (IDA): Jefferies rated Hold with a price target of $110.
• Alliant Energy (LNT): Jefferies rated Hold with a price target of $67.
• OGE Energy (OGE): Jefferies rated Buy with a price target of $46.
• Pinnacle West (PNW): Jefferies rated Buy with a price target of $104.
• Portland Gen Elec (POR): Jefferies rated Hold with a price target of $48.
• PPL Corp (PPL): Jefferies rated Buy with a price target of $38.
• Reddit (RDDT): B. Riley Securities rated Buy with a price target of $75.
• SJW (SJW): BofA Securities rated Neutral with a price target of $65.
• Snap (SNAP): B. Riley Securities rated Neutral with a price target of $11.
• Southern (SO): Jefferies rated Hold with a price target of $94.
• WEC Energy Group (WEC): Jefferies rated Hold with a price target of $102.
• Xcel Energy (XEL): Jefferies rated Hold with a price target of $70.

September 19th:

Upgrades:

• Air France-KLM (AFLYY) – Exane BNP Paribas: Underperform to Neutral
• DoorDash (DASH) – BTIG Research: Neutral to Buy with a target of $155
• Equifax (EFX) – Exane BNP Paribas: Underperform to Neutral with a target of $310
• Equity Lifestyle Properties (ELS) – Wells Fargo: Equal Weight to Overweight with a target increase from $70.5 to $82
• Prelude Therapeutics (PRLD) – H.C. Wainwright: Neutral to Buy with a target of $5
• Safehold (SAFE) – Raymond James: Market Perform to Outperform

Downgrades:

• Athira Pharma (ATHA) – Mizuho: Outperform to Neutral with a target decrease from $5 to $0.5
• Casey’s General (CASY) – JP Morgan: Neutral to Underweight with a target increase from $300 to $337
• Clear Channel Outdoor (CCO) – Wells Fargo: Overweight to Equal Weight with a target decrease from $2.75 to $1.75
• Elanco Animal Health (ELAN) – Morgan Stanley: Overweight to Equal-Weight with a target decrease from $17 to $15
• Five Below (FIVE) – JP Morgan: Neutral to Underweight with a target increase from $89 to $95
• Halozyme Therapeutics (HALO) – JP Morgan: Overweight to Neutral with a target increase from $52 to $57
• Lument Finance Trust (LFT) – Raymond James: Outperform to Market Perform
• Murphy USA (MUSA) – JP Morgan: Neutral to Underweight with a target increase from $415 to $435
• NexPoint Real Estate Finance (NREF) – Raymond James: Strong Buy to Market Perform
• Progyny (PGNY) – JMP Securities: Market Outperform to Market Perform
• Rentokil Initial plc (RTO) – Redburn Atlantic: Buy to Neutral
• Vista Outdoor (VSTO) – ROTH MKM: Buy to Neutral
• WillScot Mobile Mini (WSC) – Barclays: Overweight to Equal Weight with a target decrease from $50 to $44

Coverage Initiated:

• Abbott Labs (ABT) – Piper Sandler: Overweight with a target of $131
• Avis Budget (CAR) – Barclays: Equal Weight with a target of $105
• Charter Communications (CHTR) – RBC Capital Markets: Sector Perform with a target of $345
• Centessa Pharmaceuticals (CNTA) – B. Riley Securities: Buy with a target of $33
• Coursera (COUR) – BofA Securities: Buy with a target of $11
• Exelixis (EXEL) – UBS: Neutral with a target of $30
• Global Medical REIT (GMRE) – Alliance Global Partners: Buy with a target of $12
• Helix Energy (HLX) – Raymond James: Strong Buy with a target of $14
• Hertz Global (HTZ) – Barclays: Underweight with a target of $3
• Kodiak Gas Services (KGS) – Redburn Atlantic: Buy with a target of $35
• Kosmos Energy (KOS) – Mizuho: Neutral with a target of $5
• Lamar Advertising (LAMR) – Wells Fargo: Equal Weight with a target of $132
• Merck KGaA (MKKGY) – Goldman: Buy
• Myriad Genetics (MYGN) – Morgan Stanley: Equal-Weight with a target of $32
• NextEra Energy (NEE) – Jefferies: Hold with a target of $87
• NextEra Energy Partners (NEP) – Jefferies: Buy with a target of $28
• Northern Oil & Gas (NOG) – Mizuho: Outperform with a target of $47
• Oklo Inc. (OKLO) – B. Riley Securities: Buy with a target of $10
• Quanta Services (PWR) – Wolfe Research: Outperform with a target of $313
• Talos Energy (TALO) – Mizuho: Outperform with a target of $16
• Turning Point Brands (TPB) – ROTH MKM: Buy with a target of $50
• Wave Life Sciences (WVE) – B. Riley Securities: Buy with a target of $11
• HIVE Digital Technologies (HIVE) – Northland Capital: Outperform with a target of $5.5

September 18th:

Upgrades

• Ambac (AMBC): ROTH MKM upgraded from Neutral to Buy; Price Target increased from $13 to $15.
• Braskem SA (BAK): UBS upgraded from Neutral to Buy.
• Extra Space Storage (EXR): Jefferies upgraded from Hold to Buy; Price Target increased from $162 to $204.
• GE HealthCare (GEHC): BTIG Research upgraded from Neutral to Buy; Price Target set at $100.
• Intercontinental Hotels Group (IHG): Goldman upgraded from Neutral to Buy.
• NMI Holdings (NMIH): RBC Capital Markets upgraded from Sector Perform to Outperform; Price Target increased from $40 to $48.
• Sirius XM (SIRI): Guggenheim upgraded from Neutral to Buy; Price Target set at $30.
• SL Green Realty (SLG): Compass Point upgraded from Sell to Neutral; Price Target increased from $35 to $60.
• Ubisoft (UBSFY): BMO Capital Markets upgraded from Market Perform to Outperform.
• V.F. Corp (VFC): Barclays upgraded from Equal Weight to Overweight; Price Target increased from $19 to $22.
• Victoria’s Secret (VSCO): Barclays upgraded from Underweight to Equal Weight; Price Target increased from $23 to $25.

Downgrades

• Edwards Lifesciences (EW): Jefferies downgraded from Buy to Hold; Price Target decreased from $85 to $70.
• Incyte (INCY): Truist downgraded from Buy to Hold; Price Target decreased from $83 to $74.
• Portland Gen Elec (POR): Barclays downgraded from Overweight to Equal Weight; Price Target set at $49.
• ResMed (RMD): Wolfe Research downgraded from Peer Perform to Underperform; Price Target set at $180.
• Cencora (COR): BofA Securities downgraded from Buy to Neutral; Price Target decreased from $275 to $245.
• Sony (SONY): Daiwa Securities downgraded from Buy to Outperform.

Coverage Initiated

• Arm Holdings plc (ARM): William Blair initiated coverage with an Outperform rating.
• Broadcom (AVGO): William Blair initiated coverage with an Outperform rating.
• BeiGene (BGNE): JMP Securities initiated coverage with Market Outperform; Price Target set at $288.
• Canaan (CAN): B. Riley Securities initiated coverage with a Buy rating; Price Target set at $2.
• Choice Hotels (CHH): Goldman initiated coverage with a Sell rating; Price Target set at $105.
• Civitas Resources (CIVI): JP Morgan initiated coverage with an Overweight rating; Price Target set at $67.
• Crescent Energy Company (CRGY): JP Morgan initiated coverage with a Neutral rating; Price Target set at $12.
• CervoMed (CRVO): Chardan Capital Markets initiated coverage with a Buy rating; Price Target set at $55.
• Hyatt Hotels (H): Goldman initiated coverage with a Neutral rating; Price Target set at $151.
• Hilton Grand Vacations (HGV): Goldman initiated coverage with a Sell rating; Price Target set at $31.
• Hilton (HLT): Goldman initiated coverage with a Buy rating; Price Target set at $245.
• ICON plc (ICLR): Leerink Partners initiated coverage with an Outperform rating; Price Target set at $379.
• KKR (KKR): HSBC Securities initiated coverage with a Buy rating; Price Target set at $148.
• Marriott (MAR): Goldman initiated coverage with a Buy rating; Price Target set at $267.
• Inari (NARI): Stifel initiated coverage with a Hold rating; Price Target set at $50.
• NVIDIA (NVDA): William Blair initiated coverage with an Outperform rating.
• OSI Systems (OSIS): Wells Fargo initiated coverage with an Overweight rating; Price Target set at $170.
• Penumbra (PEN): Stifel initiated coverage with a Buy rating; Price Target set at $238.
• Rhythm Pharmaceuticals (RYTM): H.C. Wainwright initiated coverage with a Buy rating; Price Target set at $64.
• Super Micro Computer (SMCI): Needham initiated coverage with a Buy rating; Price Target set at $600.
• Talen Energy (TLN): UBS initiated coverage with a Buy rating; Price Target set at $197.
• Travel + Leisure Co (TNL): Goldman initiated coverage with a Neutral rating; Price Target set at $44.
• Marriott Vacations (VAC): Goldman initiated coverage with a Sell rating; Price Target set at $62.
• Wyndham Hotels & Resorts (WH): Goldman initiated coverage with a Buy rating; Price Target set at $96.
• Nutex Health (NUTX): Maxim Group initiated coverage with a Buy rating; Price Target set at $45.
• Lineage (LINE): CapitalOne initiated coverage with an Overweight rating; Price Target set at $91.

September 17th:

Upgrades

• AppLovin (APP): UBS upgraded from Neutral to Buy, with a price target raised from $100 to $145.
• Aramark (ARMK): RBC Capital Markets upgraded from Sector Perform to Outperform, with a price target increased from $36 to $42.5.
• BioNTech (BNTX): Jefferies upgraded from Hold to Buy, with a price target boosted from $96 to $150.
• Torrid (CURV): William Blair upgraded from Market Perform to Outperform.
• Dime Community (DCOM): Raymond James upgraded from Outperform to Strong Buy, with a price target raised from $29 to $35.
• Entergy (ETR): Barclays upgraded from Equal Weight to Overweight, with a price target increased from $115 to $138.
• Gannett (GCI): Citigroup downgraded from Sell to Neutral, with a price target of $5.1.
• GE Vernova (GEV): BofA Securities upgraded from Neutral to Buy, with a price target raised from $200 to $300.
• Hewlett Packard Enterprise (HPE): BofA Securities upgraded from Neutral to Buy, with a price target raised from $21 to $24.
• LivaNova (LIVN): Robert W. Baird upgraded from Neutral to Outperform, with a price target increased from $55 to $66.
• Lattice Semiconductor (LSCC): Stifel upgraded from Hold to Buy, with a price target of $55.
• Relmada Therapeutics (RLMD): Jefferies upgraded from Hold to Buy, with a price target increased from $3.5 to $13.
• Shopify (SHOP): Redburn Atlantic upgraded from Neutral to Buy, with a price target of $99.
• Synovus (SNV): Raymond James upgraded from Market Perform to Outperform, with a price target of $49.
• Texas Capital (TCBI): Raymond James upgraded from Market Perform to Outperform, with a price target of $78.
• Veritex Holdings (VBTX): Raymond James upgraded from Market Perform to Strong Buy, with a price target of $30.
• Alerus Financial (ALRS): Raymond James upgraded from Market Perform to Outperform, with a price target of $24.
• Banc of California (BANC): Raymond James upgraded from Market Perform to Outperform, with a price target of $16.

Downgrades

• Adecoagro S.A. (AGRO): Morgan Stanley downgraded from Overweight to Equal-Weight, with a price target reduced from $14.5 to $12.5.
• Frontier Communications Parent (FYBR): JP Morgan downgraded from Overweight to Neutral, with a price target raised from $35 to $38.5.
• Acushnet (GOLF): Jefferies downgraded from Buy to Hold, with a price target reduced from $86 to $75.
• Old Second Bancorp Inc. (OSBC): Raymond James downgraded from Strong Buy to Outperform, with a price target lowered from $19 to $18.
• Bank OZK (OZK): Raymond James downgraded from Outperform to Market Perform.
• Prosperity Bancshares (PB): Raymond James downgraded from Strong Buy to Outperform, with a price target of $80.
• SolarEdge Technologies (SEDG): Jefferies downgraded from Hold to Underperform, with a price target reduced from $27 to $17.
• Viasat (VSAT): JP Morgan downgraded from Overweight to Neutral, with a price target reduced from $29 to $15.
• Nissan Motor (NSANY): BofA Securities downgraded from Buy to Underperform.

Coverage Initiated

• Antero Resources (AR): Citigroup initiated coverage with a Neutral rating and a price target of $29.
• Dell (DELL): Mizuho initiated coverage with an Outperform rating and a price target of $135.
• Definitive Healthcare (DH): BTIG Research initiated coverage with a Buy rating and a price target of $7.
• Fidelis Insurance Holdings Limited (FIHL): Goldman initiated coverage with a Neutral rating and a price target of $18.5.
• JAKKS Pacific (JAKK): B. Riley Securities initiated coverage with a Buy rating and a price target of $37.
• Jefferies (JEF): UBS initiated coverage with a Buy rating and a price target of $67.
• Lightspeed (LSPD): The Benchmark Company initiated coverage with a Buy rating and a price target of $20.
• Oruka Therapeutics (ORKA): Leerink Partners initiated coverage with an Outperform rating and a price target of $44.
• Rhythm Pharmaceuticals (RYTM): JMP Securities initiated coverage with a Market Outperform rating and a price target of $64.
• Super Micro Computer (SMCI): Mizuho initiated coverage with a Neutral rating and a price target of $450.
• Innodata (INOD): Craig Hallum initiated coverage with a Buy rating and a price target of $23.
• Quest Resource Holdings (QRHC): Northland Capital initiated coverage with an Outperform rating and a price target of $12.5.

September 16th:

Upgrades

• Acrivon Therapeutics (ACRV)
• Brokerage Firm: Ladenburg Thalmann
• Ratings Change: Neutral >> Buy
• Price Target: $16
• Ameren (AEE)
• Brokerage Firm: Mizuho
• Ratings Change: Neutral >> Outperform
• Price Target: $82 >> $89
• BHP Group (BHP)
• Brokerage Firm: Bernstein
• Ratings Change: Market Perform >> Outperform
• Builders FirstSource (BLDR)
• Brokerage Firm: Truist
• Ratings Change: Hold >> Buy
• Price Target: $165 >> $220
• BioNTech (BNTX)
• Brokerage Firm: JP Morgan
• Ratings Change: Underweight >> Neutral
• Price Target: $91 >> $125
• Community Healthcare Trust (CHCT)
• Brokerage Firm: Evercore ISI
• Ratings Change: Underperform >> In-line
• Price Target: $21 >> $18
• Compass Therapeutics (CMPX)
• Brokerage Firm: Ladenburg Thalmann
• Ratings Change: Neutral >> Buy
• Price Target: $5
• Delek US Holdings (DK)
• Brokerage Firm: Mizuho
• Ratings Change: Underperform >> Neutral
• Price Target: $28 >> $26
• EastGroup (EGP)
• Brokerage Firm: Evercore ISI
• Ratings Change: In-line >> Outperform
• Price Target: $192 >> $204
• Entegris (ENTG)
• Brokerage Firm: Citigroup
• Ratings Change: Neutral >> Buy
• Price Target: $119 >> $130
• Chart Industries (GTLS)
• Brokerage Firm: Morgan Stanley
• Ratings Change: Equal-Weight >> Overweight
• Price Target: $175
• Kinder Morgan (KMI)
• Brokerage Firm: Morgan Stanley
• Ratings Change: Underweight >> Equal-Weight
• Price Target: $24
• ONEOK (OKE)
• Brokerage Firm: Morgan Stanley
• Ratings Change: Equal-Weight >> Overweight
• Price Target: $103 >> $111
• Oracle (ORCL)
• Brokerage Firm: Melius
• Ratings Change: Hold >> Buy
• Price Target: $210
• Sprouts Farmers Market (SFM)
• Brokerage Firm: Evercore ISI
• Ratings Change: In-line >> Outperform
• Price Target: $96 >> $120
• SL Green Realty (SLG)
• Brokerage Firm: Evercore ISI
• Ratings Change: Underperform >> In-line
• Price Target: $55 >> $66
• Simon Properties (SPG)
• Brokerage Firm: Evercore ISI
• Ratings Change: In-line >> Outperform
• Price Target: $160 >> $172
• Zillow (ZG)
• Brokerage Firm: Wedbush
• Ratings Change: Neutral >> Outperform
• Price Target: $50 >> $80
• LG Display (LPL)
• Brokerage Firm: Morgan Stanley
• Ratings Change: Equal-Weight >> Overweight
• ASE Technology (ASX)
• Brokerage Firm: Morgan Stanley
• Ratings Change: Equal-Weight >> Overweight

Downgrades

• Ally Financial (ALLY)
• Brokerage Firm: BTIG Research
• Ratings Change: Buy >> Neutral
• Colgate-Palmolive (CL)
• Brokerage Firm: Wells Fargo
• Ratings Change: Equal Weight >> Underweight
• Price Target: $100
• EnLink Midstream (ENLC)
• Brokerage Firm: Morgan Stanley
• Ratings Change: Overweight >> Equal-Weight
• Price Target: $16
• Kinsale Capital (KNSL)
• Brokerage Firm: Wolfe Research
• Ratings Change: Outperform >> Peer Perform
• MKS Instruments (MKSI)
• Brokerage Firm: Citigroup
• Ratings Change: Buy >> Neutral
• Price Target: $145 >> $120
• Nestle (NSRGY)
• Brokerage Firm: Morgan Stanley
• Ratings Change: Equal-Weight >> Underweight
• Nova Measuring (NVMI)
• Brokerage Firm: Citigroup
• Ratings Change: Buy >> Neutral
• Price Target: $273 >> $224
• Regency Centers (REG)
• Brokerage Firm: Evercore ISI
• Ratings Change: Outperform >> In-line
• Price Target: $72 >> $75
• Southern (SO)
• Brokerage Firm: Mizuho
• Ratings Change: Outperform >> Neutral
• Price Target: $90
• Sun Communities (SUI)
• Brokerage Firm: Evercore ISI
• Ratings Change: Outperform >> In-line
• Price Target: $144 >> $149
• Synchrony Financial (SYF)
• Brokerage Firm: BTIG Research
• Ratings Change: Buy >> Neutral
• Western Midstream (WES)
• Brokerage Firm: Morgan Stanley
• Ratings Change: Overweight >> Equal-Weight
• Price Target: $42
• World Kinect Corporation (WKC)
• Brokerage Firm: Morgan Stanley
• Ratings Change: Equal-Weight >> Underweight
• Price Target: $28
• AeroVironment (AVAV)
• Brokerage Firm: Raymond James
• Ratings Change: Outperform >> Market Perform

Coverage Initiated

• Arm Holdings plc (ARM)
• Brokerage Firm: The Benchmark Company
• Ratings Change: Hold
• Biohaven (BHVN)
• Brokerage Firm: Jefferies
• Ratings Change: Buy
• Price Target: $57
• Eaton (ETN)
• Brokerage Firm: Citigroup
• Ratings Change: Buy
• Price Target: $348
• GE Vernova (GEV)
• Brokerage Firm: Barclays
• Ratings Change: Overweight
• Price Target: $250
• Oruka Therapeutics (ORKA)
• Brokerage Firm: TD Cowen
• Ratings Change: Buy
• TriSalus Life Sciences (TLSI)
• Brokerage Firm: Oppenheimer
• Ratings Change: Outperform
• Price Target: $10
• Yelp (YELP)
• Brokerage Firm: BofA Securities
• Ratings Change: Underperform
• Price Target: $30
• LegalZoom.com (LZ)
• Brokerage Firm: William Blair
• Ratings Change: Market Perform
• Lineage (LINE)
• Brokerage Firm: CapitalOne
• Ratings Change: Overweight
• Price Target: $91
• Biodesix (BDSX)
• Brokerage Firm: Scotiabank
• Ratings Change: Sector Outperform
• The RealReal (REAL)
• Brokerage Firm: Northland Capital
• Ratings Change: Outperform
• Price Target: $6